Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

VE-cadherin antibody for cancer and other disorders associated with angiogenesis

July 25, 2002

New CDK inhibitors identified at BMS

July 24, 2002

AstraZeneca patent describes MEK inhibitors for use in cancer

July 23, 2002

Phase II Aroplatin trial enrolling in metastatic colorectal cancer

July 22, 2002

Selective PARP1/PARP2 inhibitors described by Iconix R&D team

July 22, 2002

New Tie-2 and/or VEGFR-2 inhibitors and their use in cancer

July 22, 2002

TNFerade enters phase IIb trial in advanced pancreatic cancer

July 19, 2002

Busulfex to undergo clinical evaluation in Japan in hematopoietic stem cell transplantation

July 19, 2002

Novel antineoplastic antibiotics produced by Streptomyces

July 19, 2002

Angiostatin enters phase II program

July 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...